CKD-330 8/5mg

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Hypertension

Phase 1

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

CompletedNCT02186496

Chong Kun Dang PharmaceuticalHypertension

Start: 2014-07-31End: 2014-11-30Updated: 2014-12-02

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

CompletedNCT02548286

Chong Kun Dang PharmaceuticalHypertension

Start: 2015-08-31End: 2015-09-30Updated: 2015-12-07